Jose E. Rivera is CLO & VP at Intellia Therapeutics, Inc. (NTLA). They have made 13 open-market trades across 1 company since 2020, most recently 2021-04-01.
CIK 0001671870
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 13 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| NTLA | 169,344 | $1.9M |
Shares reported on the most recent Form 4, priced at the 2021-04-02 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NTLA | SELL | 2021-04-01 | 2021-04-02 | $82.47 | $8.2M | -7.6% | -10.7% | +107.7% |
| NTLA | SELL | 2021-02-09 | 2021-02-09 | $75.00 | $862K | -13.1% | -13.3% | -19.8% |
| NTLA | SELL | 2021-02-01 | 2021-02-03 | $63.99 | $6.9M | +1.1% | -23.2% | +6.8% |
| NTLA | SELL | 2021-01-05 | 2021-01-05 | $55.86 | $232K | +36.5% | +12.9% | +33.7% |
| NTLA | SELL | 2020-12-01 | 2020-12-03 | $38.16 | $247K | +24.7% | +30.0% | +34.2% |
| NTLA | SELL | 2020-11-16 | 2020-11-18 | $34.41 | $353K | +12.2% | +63.1% | +100.6% |
| NTLA | SELL | 2020-11-04 | 2020-11-06 | $28.00 | $94K | +13.7% | +54.8% | +125.1% |
| NTLA | SELL | 2020-10-15 | 2020-10-16 | $24.20 | $268K | -7.9% | +29.6% | +214.3% |
| NTLA | SELL | 2020-09-15 | 2020-09-17 | $21.04 | $236K | -8.5% | +9.1% | +126.0% |
| NTLA | SELL | 2020-08-18 | 2020-08-20 | $21.00 | $118K | +4.2% | +9.5% | +68.0% |
| NTLA | SELL | 2020-07-15 | 2020-07-17 | $22.70 | $255K | -15.7% | -4.3% | +11.3% |
| NTLA | SELL | 2020-06-16 | 2020-06-18 | $21.00 | $118K | +0.6% | +6.4% | +10.0% |
| NTLA | SELL | 2020-05-26 | 2020-05-28 | $21.21 | $238K | +16.0% | +17.1% | +19.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.